This can be interpreted as IL-10 induced promotion of an anti-inflammatory response in colitis mucosa confounded with obesity, while the combination of SW and IAP treatment affording intestinal protection resulted in a downregulation of this cytokine in intestinal mucosa. The gene discussed is ALPI; the disease is obesity due to melanocortin 4 receptor deficiency.